Revolutionary Step in B2B: The First Verified & Trusted Pharma, Surgical & Medical Trade Automation Platform • Direct Factory Deals, Global Tenders & 7-Document Export Dossiers•Revolutionary Step in B2B: The First Verified & Trusted Pharma, Surgical & Medical Trade Automation Platform • Direct Factory Deals, Global Tenders & 7-Document Export Dossiers•
Home›Catalog›Antidiabetic Agents›Dapagliflozin
Antidiabetic AgentsUSP / BP / EPRx Required (Finished Dosage) / Industrial API

Dapagliflozin

Sub-Class: SGLT2 InhibitorsPrimary Therapeutic Use: SGLT2 Inhibitors - Therapeutic Sourcing Specification

🩺 Clinical Indications & Therapeutic Uses

Type 2 Diabetes, chronic kidney disease, and heart failure.

⚙️ How It Works (Mechanism of Action)

Clinical Administration & Action: Taken orally once daily.. Acts on designated receptor and enzymatic pathways according to official pharmacopeial monograph standards to achieve systemic therapeutic efficacy.

🚫 Contraindications (When Not To Use)

Known hypersensitivity to Dapagliflozin or related chemical analogs. Contraindicated in severe acute organ decompensation unless specifically managed under institutional clinical protocols.

⚠️ Precautions & Clinical Warnings

Ensure adequate hydration.

International Strengths

Strictly USP / BP reference standards

5mg10mg

Dosage Forms & Bulk API Grades

  • • Film-Coated Tablets
  • • API Bulk Powder

Trade Bulk Dapagliflozin

Supply active API raw materials or publish an official procurement tender.

🌐 International Pharmacopeia Reference Standards:

Generic specifications, molecular strengths, and indications in this catalog entry are compiled in alignment with international pharmacopeial reference standards including USP (United States Pharmacopeia), BP (British Pharmacopoeia), EP (European Pharmacopoeia), and the WHO Model List of Essential Medicines for wholesale B2B trade, regulatory dossier matching, and raw material procurement.

⚠️

Strict B2B Compliance & Non-Medical Prescription Notice:

This catalog entry is intended strictly for industrial B2B trade reference, dossier preparation, and wholesale sourcing among licensed pharmaceutical manufacturers, importers, and registered traders. It does not constitute consumer medical advice or individual prescription guidance.